Oteseconazole
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis.
Journal: Journal of women's health (2002)
Published: November 08, 2025
In vitro susceptibility profiles of 16 antifungal drugs against Trichophyton indotineae.
Journal: Microbiology spectrum
Published: June 23, 2025
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis.
Journal: Expert review of anti-infective therapy
Published: June 04, 2025
Design, Synthesis, and Biological Activity Evaluation of Deuterated Diphenyl Azole Alcohol-Based CYP51 Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 03, 2025
Vulvovaginal Candidiasis Caused by Candida krusei (Pichia kudriavzevii), Still a Formidable Challenge.
Journal: Journal of lower genital tract disease
Published: May 30, 2025
Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitor.
Journal: European journal of medicinal chemistry
Published: April 24, 2025
Rising Into Relevance: A Rare Case of Saccharomyces cerevisiae Pyelonephritis in an Immunosuppressed Patient With Exposure to Sourdough Starter.
Journal: Journal of investigative medicine high impact case reports
Published: February 24, 2025
An update on newer antifungals.
Journal: Expert review of anti-infective therapy
Published: January 30, 2025
QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation.
Journal: Cancers
Published: January 27, 2025
New pharmacotherapeutic strategies for drug-resistant Candida infections: a review.
Journal: Expert opinion on pharmacotherapy
Published: November 25, 2024
Last Updated: 02/24/2026